Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

KOL Strategy

- PMLiVE

McCarthy leaves NHS England

Policy director set for move to the University of Bradford

- PMLiVE

FDA approves new indication for Pfizer/BMS’ Eliquis

Oral anticoagulant gains US approval for deep vein thrombosis use

- PMLiVE

Galapagos divests CRO operations to pursue biotech path

Sells Argenta and BioFocus to Charles River Laboratories for up to €134m

- PMLiVE

Novella Clinical appoints Dr Chris Smyth to head European and Asian operations

He joins the Quintiles company from fellow CRO INC Research

- PMLiVE

Smartphone gamers take one month to decode six months of genetic data

Cancer Research UK details first progress from its new mobile game

- PMLiVE

This month in 1996: Ciba-Geigy and Sandoz merge

The story behind Novartis’ formation resonates today

UK flag

UK gets its own ‘breakthrough’ status for early medicines access

But concerns remain over funding

- PMLiVE

Teva backs UK’s dementia drive with $21m investment

Pharma company will support National Institute for Health Research

- PMLiVE

Novo Nordisk will build $100m facility in Denmark

Bagsvaerd site will support growing diabetes pipeline

- PMLiVE

Celgene appoints UK inflammation and immunology director

Rob Moore joins from Abbott

- PMLiVE

Physicians Interactive acquires Tomorrow Networks

Deal gives PI access to more than 50 million US healthcare professionals and consumers

Pharma deals during February 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links